Inspire Medical Systems, Inc. (NYSE:INSP) will be discussing 3Q20 financial results with the investment community.on 2nd November 2020 at 5:00 PM eastern time.
Those interested in listening to the conference call live via the Internet can visit www.inspiresleep.com
Earnings Expectation
Inspire Medical Systems, Inc. is reporting third quarter financial results on Monday 2nd November 2020, after market close.
According to analysts surveyed by Thomson Reuters, INSP is expected to report 3Q20 loss of $ 0.72 per share from revenue of $ 22.75 million.
For the full year, analysts anticipate top line of $ 90.19 million, while looking forward to loss of $ 2.8 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 88.00 million ~ $ 92.00 million
Click Here For More Historical Outlooks Of Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The company also develops a novel, a closed-loop solution that continuously monitors a patients breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway.
